Last reviewed · How we verify
Bacterial conjunctivitis
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Tobi · Novartis
- Avelox · Bayer AG
Fourth-generation fluoroquinolone with the broadest spectrum, covering gram-positive, gram-negative, anaerobic, and atypical organisms. - Trimethoprim · Dr Reddys Labs Sa
- Ciprofloxacine · Poitiers University Hospital
- Vantobra · Pfizer
- Gentamicin · Merck & Co.
- Nebcin · University Hospital, Lille
- Avelox · Novartis Pharmaceuticals
- Besivance · Bausch Health
Besivance works by inhibiting bacterial DNA replication. - besivance · Ophthalmology Consultants, Ltd.
- Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life. - Zymar · Allergan
- Cortisporin · Pfizer
- Gramoderm · Pfizer
- Noroxin
- Floxin
- Cipro · Bayer AG
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Bacterial conjunctivitis patent landscape — cliff calendar, originator estates, attackable patents
- Bacterial conjunctivitis treatment landscape brief
- Bacterial conjunctivitis treatment updates RSS
Frequently asked questions about Bacterial conjunctivitis
What drugs treat Bacterial conjunctivitis?
Tracked treatments include Ramycin, Garamycin, Tobi, Avelox, Trimethoprim, Ciprofloxacine, Vantobra, Gentamicin.
What is the treatment for Bacterial conjunctivitis?
Standard treatment for Bacterial conjunctivitis includes Ramycin, Garamycin, Tobi, Avelox, Trimethoprim. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Bacterial conjunctivitis patent cliff · Bacterial conjunctivitis CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Tobi · Novartis
- Treatment: Avelox · Bayer AG
- Treatment: Trimethoprim · Dr Reddys Labs Sa
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing